Oncaspar J Code: J9266

Drug & Product Overview

HCPCS Descriptor Injection, pegaspargase, per single dose vial

HCPCS Added Date January 1, 1996

Manufacturer Servier Pharmaceuticals

Route of Administration Intramuscular, Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution

About Oncaspar

Oncaspar is a medication aligned to the HCPCS J Code: J9266 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intramuscular or intravenous routes and manufactured by Servier Pharmaceuticals.

According to CMS Drug Use Information: This medication is usually used to treat acute lymphocytic leukemia (ALL), especially in patients who are allergic to L-asparaginase. It works by starving tumor cells of a certain amino acid (asparagine), causing the tumor cells to die.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
72694-0954-01	Oncaspar	Servier Pharmaceuticals LLC	1	Oncaspar Intramuscular Injection 3750 … Login for More

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Oncaspar Pricing & Reimbursement

J9266 Private Payer Reimbursement

$29,470.12 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

Oncaspar Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 0%

Avg. Days to File 40.0days

Avg. Days to Pay 13.4days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9266 claims analytics on FocalPoint →

Oncaspar CPT Administration Codes

CPT Code	Description
96401	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Login for More	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) Login for More

JW / JZ modifiers apply

CMS has identified Oncaspar (J9266) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

Oncaspar Medically Unlikely Edits (MUE)

The most billing units of J9266 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 each.

Practitioner Office & Hospital Outpatient

2 units / day

Same limit in both settings

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Oncaspar Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia with hypersensitivity to native L-asparaginase

Drug Class

Asparaginase [CS]Asparagine-specific Enzyme [EPC]

Frequently Asked Questions

Is there an available Oncaspar billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for Oncaspar.

Are there any available Oncaspar patient assistance programs?

Oncaspar patient assistance information can be found through Servier Pharmaceuticals. Visit Here →

Where can I find Oncaspar prescribing information?

Oncaspar prescribing information can be found at the link below: Visit Here →

Where can I find Oncaspar side effect information?

Information regarding Oncaspar's side effects can be found at MedlinePlus Visit Here →

Does billing Oncaspar require JZ/JW wastage modifiers?

CMS has identified Oncaspar(J9266) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.